Investor Relations

Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.


MISSISSAUGA, Ontario, March 11, 2011 /PRNewswire via COMTEX/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that effective March 10, 2011, the company completed its previously announced acquisition of PharmaSwiss S.A.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at

Contact Information:

Laurie W. Little



Copyright © 2012 Valeant. All rights reserved.